Posted On: 01/23/2013 9:41:25 PM
Post# of 63824

NBIX. Uptrend. PR after hours. $9.19
Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor


NBIX. Uptrend. PR after hours. $9.19